nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A5—prostate cancer	0.175	0.698	CbGaD
Risperidone—CYP3A4—prostate cancer	0.0755	0.302	CbGaD
Risperidone—CYP3A5—Flutamide—prostate cancer	0.0247	0.0684	CbGbCtD
Risperidone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0222	0.0613	CbGbCtD
Risperidone—CYP2D6—Bicalutamide—prostate cancer	0.0183	0.0506	CbGbCtD
Risperidone—CYP3A5—Cabazitaxel—prostate cancer	0.0183	0.0506	CbGbCtD
Risperidone—ABCB1—Estramustine—prostate cancer	0.0181	0.05	CbGbCtD
Risperidone—CYP3A5—Estrone—prostate cancer	0.0179	0.0495	CbGbCtD
Risperidone—CYP2D6—Abiraterone—prostate cancer	0.0152	0.042	CbGbCtD
Risperidone—ADRA1B—vas deferens—prostate cancer	0.0139	0.255	CbGeAlD
Risperidone—CYP3A7—Estradiol—prostate cancer	0.0137	0.0379	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0137	0.0379	CbGbCtD
Risperidone—ABCB1—Cabazitaxel—prostate cancer	0.0119	0.0329	CbGbCtD
Risperidone—CYP3A4—Bicalutamide—prostate cancer	0.0116	0.0322	CbGbCtD
Risperidone—ABCB1—Estrone—prostate cancer	0.0116	0.0322	CbGbCtD
Risperidone—CYP3A4—Estramustine—prostate cancer	0.0108	0.0299	CbGbCtD
Risperidone—ABCB1—Ethinyl Estradiol—prostate cancer	0.0104	0.0287	CbGbCtD
Risperidone—CYP3A5—Estradiol—prostate cancer	0.0103	0.0284	CbGbCtD
Risperidone—CYP3A4—Flutamide—prostate cancer	0.00965	0.0267	CbGbCtD
Risperidone—CYP3A4—Abiraterone—prostate cancer	0.00965	0.0267	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00818	0.0226	CbGbCtD
Risperidone—CYP3A7—Docetaxel—prostate cancer	0.00818	0.0226	CbGbCtD
Risperidone—HTR7—vas deferens—prostate cancer	0.00813	0.148	CbGeAlD
Risperidone—ABCB1—Conjugated Estrogens—prostate cancer	0.00762	0.0211	CbGbCtD
Risperidone—CYP3A4—Cabazitaxel—prostate cancer	0.00714	0.0197	CbGbCtD
Risperidone—CYP3A4—Estrone—prostate cancer	0.00698	0.0193	CbGbCtD
Risperidone—ABCB1—Mitoxantrone—prostate cancer	0.00693	0.0191	CbGbCtD
Risperidone—CYP3A5—Etoposide—prostate cancer	0.00671	0.0186	CbGbCtD
Risperidone—ABCB1—Estradiol—prostate cancer	0.00669	0.0185	CbGbCtD
Risperidone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00622	0.0172	CbGbCtD
Risperidone—CYP3A5—Docetaxel—prostate cancer	0.00614	0.017	CbGbCtD
Risperidone—ABCB1—Prednisone—prostate cancer	0.00575	0.0159	CbGbCtD
Risperidone—H1F0—semen—prostate cancer	0.00469	0.0856	CbGeAlD
Risperidone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00456	0.0126	CbGbCtD
Risperidone—ABCB1—Etoposide—prostate cancer	0.00437	0.0121	CbGbCtD
Risperidone—CYP3A4—Mitoxantrone—prostate cancer	0.00415	0.0115	CbGbCtD
Risperidone—CYP3A4—Estradiol—prostate cancer	0.00401	0.0111	CbGbCtD
Risperidone—ABCB1—Docetaxel—prostate cancer	0.004	0.011	CbGbCtD
Risperidone—CYP3A4—Prednisone—prostate cancer	0.00345	0.00953	CbGbCtD
Risperidone—ABCB1—Doxorubicin—prostate cancer	0.00298	0.00823	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—prostate cancer	0.00281	0.00776	CbGbCtD
Risperidone—CYP3A4—Etoposide—prostate cancer	0.00262	0.00723	CbGbCtD
Risperidone—CYP3A4—Docetaxel—prostate cancer	0.00239	0.00662	CbGbCtD
Risperidone—CYP3A4—Doxorubicin—prostate cancer	0.00178	0.00493	CbGbCtD
Risperidone—HTR2A—urine—prostate cancer	0.00126	0.023	CbGeAlD
Risperidone—H1F0—prostate gland—prostate cancer	0.00118	0.0215	CbGeAlD
Risperidone—CYP3A4—urine—prostate cancer	0.00117	0.0213	CbGeAlD
Risperidone—CYP2D6—urine—prostate cancer	0.00115	0.021	CbGeAlD
Risperidone—DRD4—testis—prostate cancer	0.00102	0.0186	CbGeAlD
Risperidone—H1F0—seminal vesicle—prostate cancer	0.000995	0.0182	CbGeAlD
Risperidone—ADRA1B—renal system—prostate cancer	0.000849	0.0155	CbGeAlD
Risperidone—H1F0—renal system—prostate cancer	0.000801	0.0146	CbGeAlD
Risperidone—H1F0—urethra—prostate cancer	0.000787	0.0144	CbGeAlD
Risperidone—Paliperidone—CYP3A5—prostate cancer	0.000757	0.343	CrCbGaD
Risperidone—ADRA1A—prostate gland—prostate cancer	0.0007	0.0128	CbGeAlD
Risperidone—KCNH2—prostate gland—prostate cancer	0.000676	0.0123	CbGeAlD
Risperidone—ADRA2C—prostate gland—prostate cancer	0.000667	0.0122	CbGeAlD
Risperidone—H1F0—bone marrow—prostate cancer	0.000606	0.0111	CbGeAlD
Risperidone—KCNH2—seminal vesicle—prostate cancer	0.000572	0.0104	CbGeAlD
Risperidone—ADRA2C—seminal vesicle—prostate cancer	0.000564	0.0103	CbGeAlD
Risperidone—CYP3A5—prostate gland—prostate cancer	0.000558	0.0102	CbGeAlD
Risperidone—HRH1—prostate gland—prostate cancer	0.000542	0.00989	CbGeAlD
Risperidone—HTR7—epithelium—prostate cancer	0.000533	0.00973	CbGeAlD
Risperidone—ADRA2A—prostate gland—prostate cancer	0.000532	0.00971	CbGeAlD
Risperidone—Iloperidone—CYP3A5—prostate cancer	0.000529	0.24	CrCbGaD
Risperidone—H1F0—testis—prostate cancer	0.000518	0.00946	CbGeAlD
Risperidone—HTR1A—renal system—prostate cancer	0.000517	0.00945	CbGeAlD
Risperidone—ADRA1A—epithelium—prostate cancer	0.000514	0.00939	CbGeAlD
Risperidone—HTR7—renal system—prostate cancer	0.000495	0.00903	CbGeAlD
Risperidone—ADRA1A—renal system—prostate cancer	0.000477	0.00871	CbGeAlD
Risperidone—KCNH2—renal system—prostate cancer	0.000461	0.00841	CbGeAlD
Risperidone—ADRA2C—renal system—prostate cancer	0.000455	0.0083	CbGeAlD
Risperidone—KCNH2—urethra—prostate cancer	0.000453	0.00826	CbGeAlD
Risperidone—ADRA2A—seminal vesicle—prostate cancer	0.00045	0.00822	CbGeAlD
Risperidone—ADRA2C—urethra—prostate cancer	0.000447	0.00815	CbGeAlD
Risperidone—HRH1—epithelium—prostate cancer	0.000398	0.00727	CbGeAlD
Risperidone—CYP3A5—renal system—prostate cancer	0.00038	0.00694	CbGeAlD
Risperidone—H1F0—lymph node—prostate cancer	0.000375	0.00685	CbGeAlD
Risperidone—Iloperidone—CYP2E1—prostate cancer	0.000364	0.165	CrCbGaD
Risperidone—HRH1—urethra—prostate cancer	0.000363	0.00662	CbGeAlD
Risperidone—ADRA2A—urethra—prostate cancer	0.000356	0.0065	CbGeAlD
Risperidone—KCNH2—bone marrow—prostate cancer	0.000348	0.00636	CbGeAlD
Risperidone—HTR2A—epithelium—prostate cancer	0.000332	0.00607	CbGeAlD
Risperidone—Paliperidone—CYP3A4—prostate cancer	0.000328	0.148	CrCbGaD
Risperidone—HTR7—testis—prostate cancer	0.00032	0.00584	CbGeAlD
Risperidone—HTR2A—renal system—prostate cancer	0.000308	0.00563	CbGeAlD
Risperidone—DRD2—testis—prostate cancer	0.000302	0.00552	CbGeAlD
Risperidone—KCNH2—testis—prostate cancer	0.000298	0.00544	CbGeAlD
Risperidone—ABCB1—prostate gland—prostate cancer	0.000297	0.00541	CbGeAlD
Risperidone—ADRA2C—testis—prostate cancer	0.000294	0.00536	CbGeAlD
Risperidone—CYP3A4—renal system—prostate cancer	0.000286	0.00521	CbGeAlD
Risperidone—CYP2D6—renal system—prostate cancer	0.000281	0.00513	CbGeAlD
Risperidone—HTR2B—lymph node—prostate cancer	0.000271	0.00494	CbGeAlD
Risperidone—ABCB1—seminal vesicle—prostate cancer	0.000251	0.00458	CbGeAlD
Risperidone—HRH1—testis—prostate cancer	0.000239	0.00436	CbGeAlD
Risperidone—ADRA2A—testis—prostate cancer	0.000234	0.00428	CbGeAlD
Risperidone—Iloperidone—CYP3A4—prostate cancer	0.000229	0.104	CrCbGaD
Risperidone—ABCB1—epithelium—prostate cancer	0.000218	0.00398	CbGeAlD
Risperidone—KCNH2—lymph node—prostate cancer	0.000216	0.00394	CbGeAlD
Risperidone—ADRA2C—lymph node—prostate cancer	0.000213	0.00389	CbGeAlD
Risperidone—ABCB1—renal system—prostate cancer	0.000202	0.00369	CbGeAlD
Risperidone—HTR2A—testis—prostate cancer	0.000199	0.00364	CbGeAlD
Risperidone—ABCB1—urethra—prostate cancer	0.000199	0.00362	CbGeAlD
Risperidone—CYP2D6—testis—prostate cancer	0.000182	0.00331	CbGeAlD
Risperidone—HRH1—lymph node—prostate cancer	0.000173	0.00316	CbGeAlD
Risperidone—ADRA2A—lymph node—prostate cancer	0.00017	0.0031	CbGeAlD
Risperidone—ABCB1—bone marrow—prostate cancer	0.000153	0.00279	CbGeAlD
Risperidone—ABCB1—testis—prostate cancer	0.000131	0.00238	CbGeAlD
Risperidone—ABCB1—lymph node—prostate cancer	9.47e-05	0.00173	CbGeAlD
Risperidone—Haemoglobin—Doxorubicin—prostate cancer	1.87e-05	8.21e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.86e-05	8.2e-05	CcSEcCtD
Risperidone—Flushing—Epirubicin—prostate cancer	1.86e-05	8.19e-05	CcSEcCtD
Risperidone—Cardiac disorder—Epirubicin—prostate cancer	1.86e-05	8.19e-05	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—prostate cancer	1.86e-05	8.19e-05	CcSEcCtD
Risperidone—Dyspepsia—Docetaxel—prostate cancer	1.86e-05	8.19e-05	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—prostate cancer	1.86e-05	8.17e-05	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—prostate cancer	1.86e-05	8.17e-05	CcSEcCtD
Risperidone—Insomnia—Capecitabine—prostate cancer	1.85e-05	8.14e-05	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—prostate cancer	1.85e-05	8.13e-05	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—prostate cancer	1.84e-05	8.11e-05	CcSEcCtD
Risperidone—Paraesthesia—Capecitabine—prostate cancer	1.84e-05	8.08e-05	CcSEcCtD
Risperidone—Decreased appetite—Docetaxel—prostate cancer	1.84e-05	8.08e-05	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—prostate cancer	1.83e-05	8.07e-05	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—prostate cancer	1.83e-05	8.05e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Docetaxel—prostate cancer	1.82e-05	8.03e-05	CcSEcCtD
Risperidone—Asthenia—Etoposide—prostate cancer	1.82e-05	8.03e-05	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—prostate cancer	1.82e-05	8.03e-05	CcSEcCtD
Risperidone—Dyspnoea—Capecitabine—prostate cancer	1.82e-05	8.03e-05	CcSEcCtD
Risperidone—Oedema—Prednisone—prostate cancer	1.82e-05	8.02e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Prednisone—prostate cancer	1.82e-05	8.02e-05	CcSEcCtD
Risperidone—Fatigue—Docetaxel—prostate cancer	1.82e-05	8.02e-05	CcSEcCtD
Risperidone—Angiopathy—Epirubicin—prostate cancer	1.82e-05	8.01e-05	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—prostate cancer	1.82e-05	8.01e-05	CcSEcCtD
Risperidone—Nausea—Mitoxantrone—prostate cancer	1.82e-05	7.99e-05	CcSEcCtD
Risperidone—Immune system disorder—Epirubicin—prostate cancer	1.81e-05	7.97e-05	CcSEcCtD
Risperidone—Infection—Prednisone—prostate cancer	1.81e-05	7.97e-05	CcSEcCtD
Risperidone—Mediastinal disorder—Epirubicin—prostate cancer	1.81e-05	7.96e-05	CcSEcCtD
Risperidone—Pain—Docetaxel—prostate cancer	1.81e-05	7.95e-05	CcSEcCtD
Risperidone—Constipation—Docetaxel—prostate cancer	1.81e-05	7.95e-05	CcSEcCtD
Risperidone—Dyspepsia—Capecitabine—prostate cancer	1.8e-05	7.93e-05	CcSEcCtD
Risperidone—Chills—Epirubicin—prostate cancer	1.8e-05	7.92e-05	CcSEcCtD
Risperidone—Pruritus—Etoposide—prostate cancer	1.8e-05	7.92e-05	CcSEcCtD
Risperidone—Shock—Prednisone—prostate cancer	1.79e-05	7.89e-05	CcSEcCtD
Risperidone—Arrhythmia—Epirubicin—prostate cancer	1.79e-05	7.89e-05	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—prostate cancer	1.79e-05	7.87e-05	CcSEcCtD
Risperidone—Nervous system disorder—Prednisone—prostate cancer	1.79e-05	7.87e-05	CcSEcCtD
Risperidone—Tachycardia—Prednisone—prostate cancer	1.78e-05	7.83e-05	CcSEcCtD
Risperidone—Decreased appetite—Capecitabine—prostate cancer	1.78e-05	7.83e-05	CcSEcCtD
Risperidone—Alopecia—Epirubicin—prostate cancer	1.77e-05	7.8e-05	CcSEcCtD
Risperidone—Skin disorder—Prednisone—prostate cancer	1.77e-05	7.79e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Capecitabine—prostate cancer	1.77e-05	7.77e-05	CcSEcCtD
Risperidone—Fatigue—Capecitabine—prostate cancer	1.76e-05	7.76e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisone—prostate cancer	1.76e-05	7.75e-05	CcSEcCtD
Risperidone—Mental disorder—Epirubicin—prostate cancer	1.76e-05	7.73e-05	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—prostate cancer	1.75e-05	7.72e-05	CcSEcCtD
Risperidone—Pain—Capecitabine—prostate cancer	1.75e-05	7.7e-05	CcSEcCtD
Risperidone—Constipation—Capecitabine—prostate cancer	1.75e-05	7.7e-05	CcSEcCtD
Risperidone—Malnutrition—Epirubicin—prostate cancer	1.75e-05	7.69e-05	CcSEcCtD
Risperidone—Erythema—Epirubicin—prostate cancer	1.75e-05	7.69e-05	CcSEcCtD
Risperidone—Feeling abnormal—Docetaxel—prostate cancer	1.74e-05	7.66e-05	CcSEcCtD
Risperidone—Diarrhoea—Etoposide—prostate cancer	1.74e-05	7.66e-05	CcSEcCtD
Risperidone—Anorexia—Prednisone—prostate cancer	1.74e-05	7.64e-05	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—prostate cancer	1.73e-05	7.63e-05	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—prostate cancer	1.73e-05	7.62e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Docetaxel—prostate cancer	1.73e-05	7.6e-05	CcSEcCtD
Risperidone—Flushing—Doxorubicin—prostate cancer	1.72e-05	7.58e-05	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—prostate cancer	1.72e-05	7.58e-05	CcSEcCtD
Risperidone—Flatulence—Epirubicin—prostate cancer	1.72e-05	7.57e-05	CcSEcCtD
Risperidone—Tension—Epirubicin—prostate cancer	1.71e-05	7.54e-05	CcSEcCtD
Risperidone—Dysgeusia—Epirubicin—prostate cancer	1.71e-05	7.53e-05	CcSEcCtD
Risperidone—Nervousness—Epirubicin—prostate cancer	1.7e-05	7.46e-05	CcSEcCtD
Risperidone—Back pain—Epirubicin—prostate cancer	1.69e-05	7.43e-05	CcSEcCtD
Risperidone—Feeling abnormal—Capecitabine—prostate cancer	1.69e-05	7.42e-05	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—prostate cancer	1.68e-05	7.41e-05	CcSEcCtD
Risperidone—Dizziness—Etoposide—prostate cancer	1.68e-05	7.4e-05	CcSEcCtD
Risperidone—Muscle spasms—Epirubicin—prostate cancer	1.68e-05	7.39e-05	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—prostate cancer	1.68e-05	7.38e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Capecitabine—prostate cancer	1.67e-05	7.36e-05	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—prostate cancer	1.67e-05	7.36e-05	CcSEcCtD
Risperidone—Abdominal pain—Docetaxel—prostate cancer	1.67e-05	7.35e-05	CcSEcCtD
Risperidone—Body temperature increased—Docetaxel—prostate cancer	1.67e-05	7.35e-05	CcSEcCtD
Risperidone—Chills—Doxorubicin—prostate cancer	1.67e-05	7.33e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Prednisone—prostate cancer	1.66e-05	7.31e-05	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—prostate cancer	1.66e-05	7.3e-05	CcSEcCtD
Risperidone—Insomnia—Prednisone—prostate cancer	1.65e-05	7.25e-05	CcSEcCtD
Risperidone—Vision blurred—Epirubicin—prostate cancer	1.65e-05	7.24e-05	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—prostate cancer	1.64e-05	7.22e-05	CcSEcCtD
Risperidone—Paraesthesia—Prednisone—prostate cancer	1.64e-05	7.2e-05	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—prostate cancer	1.63e-05	7.16e-05	CcSEcCtD
Risperidone—Urticaria—Capecitabine—prostate cancer	1.62e-05	7.15e-05	CcSEcCtD
Risperidone—Ill-defined disorder—Epirubicin—prostate cancer	1.62e-05	7.13e-05	CcSEcCtD
Risperidone—Abdominal pain—Capecitabine—prostate cancer	1.62e-05	7.12e-05	CcSEcCtD
Risperidone—Body temperature increased—Capecitabine—prostate cancer	1.62e-05	7.12e-05	CcSEcCtD
Risperidone—Vomiting—Etoposide—prostate cancer	1.62e-05	7.11e-05	CcSEcCtD
Risperidone—Erythema—Doxorubicin—prostate cancer	1.62e-05	7.11e-05	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—prostate cancer	1.62e-05	7.11e-05	CcSEcCtD
Risperidone—Anaemia—Epirubicin—prostate cancer	1.61e-05	7.1e-05	CcSEcCtD
Risperidone—Agitation—Epirubicin—prostate cancer	1.6e-05	7.06e-05	CcSEcCtD
Risperidone—Dyspepsia—Prednisone—prostate cancer	1.6e-05	7.06e-05	CcSEcCtD
Risperidone—Rash—Etoposide—prostate cancer	1.6e-05	7.06e-05	CcSEcCtD
Risperidone—Dermatitis—Etoposide—prostate cancer	1.6e-05	7.05e-05	CcSEcCtD
Risperidone—Headache—Etoposide—prostate cancer	1.59e-05	7.01e-05	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—prostate cancer	1.59e-05	7.01e-05	CcSEcCtD
Risperidone—Tension—Doxorubicin—prostate cancer	1.59e-05	6.98e-05	CcSEcCtD
Risperidone—Decreased appetite—Prednisone—prostate cancer	1.58e-05	6.97e-05	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—prostate cancer	1.58e-05	6.96e-05	CcSEcCtD
Risperidone—Malaise—Epirubicin—prostate cancer	1.57e-05	6.93e-05	CcSEcCtD
Risperidone—Fatigue—Prednisone—prostate cancer	1.57e-05	6.91e-05	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—prostate cancer	1.57e-05	6.91e-05	CcSEcCtD
Risperidone—Vertigo—Epirubicin—prostate cancer	1.57e-05	6.91e-05	CcSEcCtD
Risperidone—Syncope—Epirubicin—prostate cancer	1.57e-05	6.89e-05	CcSEcCtD
Risperidone—Leukopenia—Epirubicin—prostate cancer	1.56e-05	6.88e-05	CcSEcCtD
Risperidone—Back pain—Doxorubicin—prostate cancer	1.56e-05	6.88e-05	CcSEcCtD
Risperidone—Constipation—Prednisone—prostate cancer	1.56e-05	6.86e-05	CcSEcCtD
Risperidone—Hypersensitivity—Docetaxel—prostate cancer	1.56e-05	6.85e-05	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—prostate cancer	1.55e-05	6.84e-05	CcSEcCtD
Risperidone—Palpitations—Epirubicin—prostate cancer	1.54e-05	6.79e-05	CcSEcCtD
Risperidone—Loss of consciousness—Epirubicin—prostate cancer	1.53e-05	6.76e-05	CcSEcCtD
Risperidone—Cough—Epirubicin—prostate cancer	1.52e-05	6.71e-05	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—prostate cancer	1.52e-05	6.7e-05	CcSEcCtD
Risperidone—Asthenia—Docetaxel—prostate cancer	1.52e-05	6.67e-05	CcSEcCtD
Risperidone—Convulsion—Epirubicin—prostate cancer	1.51e-05	6.66e-05	CcSEcCtD
Risperidone—Nausea—Etoposide—prostate cancer	1.51e-05	6.65e-05	CcSEcCtD
Risperidone—Hypertension—Epirubicin—prostate cancer	1.51e-05	6.64e-05	CcSEcCtD
Risperidone—Hypersensitivity—Capecitabine—prostate cancer	1.51e-05	6.63e-05	CcSEcCtD
Risperidone—Feeling abnormal—Prednisone—prostate cancer	1.5e-05	6.61e-05	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—prostate cancer	1.5e-05	6.6e-05	CcSEcCtD
Risperidone—Pruritus—Docetaxel—prostate cancer	1.49e-05	6.58e-05	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—prostate cancer	1.49e-05	6.57e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Prednisone—prostate cancer	1.49e-05	6.56e-05	CcSEcCtD
Risperidone—Arthralgia—Epirubicin—prostate cancer	1.49e-05	6.54e-05	CcSEcCtD
Risperidone—Chest pain—Epirubicin—prostate cancer	1.49e-05	6.54e-05	CcSEcCtD
Risperidone—Myalgia—Epirubicin—prostate cancer	1.49e-05	6.54e-05	CcSEcCtD
Risperidone—Agitation—Doxorubicin—prostate cancer	1.48e-05	6.54e-05	CcSEcCtD
Risperidone—Anxiety—Epirubicin—prostate cancer	1.48e-05	6.52e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.48e-05	6.5e-05	CcSEcCtD
Risperidone—Discomfort—Epirubicin—prostate cancer	1.47e-05	6.46e-05	CcSEcCtD
Risperidone—Asthenia—Capecitabine—prostate cancer	1.47e-05	6.46e-05	CcSEcCtD
Risperidone—Malaise—Doxorubicin—prostate cancer	1.46e-05	6.41e-05	CcSEcCtD
Risperidone—Dry mouth—Epirubicin—prostate cancer	1.45e-05	6.4e-05	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—prostate cancer	1.45e-05	6.39e-05	CcSEcCtD
Risperidone—Syncope—Doxorubicin—prostate cancer	1.45e-05	6.38e-05	CcSEcCtD
Risperidone—Urticaria—Prednisone—prostate cancer	1.45e-05	6.37e-05	CcSEcCtD
Risperidone—Pruritus—Capecitabine—prostate cancer	1.45e-05	6.37e-05	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—prostate cancer	1.45e-05	6.37e-05	CcSEcCtD
Risperidone—Diarrhoea—Docetaxel—prostate cancer	1.45e-05	6.36e-05	CcSEcCtD
Risperidone—Abdominal pain—Prednisone—prostate cancer	1.44e-05	6.34e-05	CcSEcCtD
Risperidone—Body temperature increased—Prednisone—prostate cancer	1.44e-05	6.34e-05	CcSEcCtD
Risperidone—Confusional state—Epirubicin—prostate cancer	1.44e-05	6.32e-05	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—prostate cancer	1.43e-05	6.28e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Epirubicin—prostate cancer	1.42e-05	6.27e-05	CcSEcCtD
Risperidone—Oedema—Epirubicin—prostate cancer	1.42e-05	6.27e-05	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—prostate cancer	1.42e-05	6.25e-05	CcSEcCtD
Risperidone—Infection—Epirubicin—prostate cancer	1.42e-05	6.23e-05	CcSEcCtD
Risperidone—Cough—Doxorubicin—prostate cancer	1.41e-05	6.21e-05	CcSEcCtD
Risperidone—Shock—Epirubicin—prostate cancer	1.4e-05	6.17e-05	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—prostate cancer	1.4e-05	6.16e-05	CcSEcCtD
Risperidone—Diarrhoea—Capecitabine—prostate cancer	1.4e-05	6.16e-05	CcSEcCtD
Risperidone—Nervous system disorder—Epirubicin—prostate cancer	1.4e-05	6.15e-05	CcSEcCtD
Risperidone—Dizziness—Docetaxel—prostate cancer	1.4e-05	6.15e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Epirubicin—prostate cancer	1.4e-05	6.14e-05	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—prostate cancer	1.39e-05	6.14e-05	CcSEcCtD
Risperidone—Tachycardia—Epirubicin—prostate cancer	1.39e-05	6.12e-05	CcSEcCtD
Risperidone—Skin disorder—Epirubicin—prostate cancer	1.38e-05	6.09e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Epirubicin—prostate cancer	1.38e-05	6.06e-05	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—prostate cancer	1.38e-05	6.05e-05	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—prostate cancer	1.38e-05	6.05e-05	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—prostate cancer	1.38e-05	6.05e-05	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—prostate cancer	1.37e-05	6.03e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.37e-05	6.01e-05	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—prostate cancer	1.36e-05	5.98e-05	CcSEcCtD
Risperidone—Anorexia—Epirubicin—prostate cancer	1.36e-05	5.98e-05	CcSEcCtD
Risperidone—Dizziness—Capecitabine—prostate cancer	1.35e-05	5.95e-05	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—prostate cancer	1.34e-05	5.92e-05	CcSEcCtD
Risperidone—Vomiting—Docetaxel—prostate cancer	1.34e-05	5.91e-05	CcSEcCtD
Risperidone—Hypersensitivity—Prednisone—prostate cancer	1.34e-05	5.91e-05	CcSEcCtD
Risperidone—Rash—Docetaxel—prostate cancer	1.33e-05	5.86e-05	CcSEcCtD
Risperidone—Hypotension—Epirubicin—prostate cancer	1.33e-05	5.86e-05	CcSEcCtD
Risperidone—Dermatitis—Docetaxel—prostate cancer	1.33e-05	5.86e-05	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—prostate cancer	1.33e-05	5.85e-05	CcSEcCtD
Risperidone—Headache—Docetaxel—prostate cancer	1.32e-05	5.83e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—prostate cancer	1.32e-05	5.8e-05	CcSEcCtD
Risperidone—Oedema—Doxorubicin—prostate cancer	1.32e-05	5.8e-05	CcSEcCtD
Risperidone—Infection—Doxorubicin—prostate cancer	1.31e-05	5.77e-05	CcSEcCtD
Risperidone—Asthenia—Prednisone—prostate cancer	1.31e-05	5.75e-05	CcSEcCtD
Risperidone—Vomiting—Capecitabine—prostate cancer	1.3e-05	5.72e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.3e-05	5.71e-05	CcSEcCtD
Risperidone—Shock—Doxorubicin—prostate cancer	1.3e-05	5.71e-05	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—prostate cancer	1.29e-05	5.69e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—prostate cancer	1.29e-05	5.68e-05	CcSEcCtD
Risperidone—Rash—Capecitabine—prostate cancer	1.29e-05	5.68e-05	CcSEcCtD
Risperidone—Pruritus—Prednisone—prostate cancer	1.29e-05	5.67e-05	CcSEcCtD
Risperidone—Insomnia—Epirubicin—prostate cancer	1.29e-05	5.67e-05	CcSEcCtD
Risperidone—Dermatitis—Capecitabine—prostate cancer	1.29e-05	5.67e-05	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—prostate cancer	1.29e-05	5.66e-05	CcSEcCtD
Risperidone—Headache—Capecitabine—prostate cancer	1.28e-05	5.64e-05	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—prostate cancer	1.28e-05	5.64e-05	CcSEcCtD
Risperidone—Paraesthesia—Epirubicin—prostate cancer	1.28e-05	5.63e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—prostate cancer	1.27e-05	5.61e-05	CcSEcCtD
Risperidone—Dyspnoea—Epirubicin—prostate cancer	1.27e-05	5.59e-05	CcSEcCtD
Risperidone—Somnolence—Epirubicin—prostate cancer	1.27e-05	5.58e-05	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—prostate cancer	1.26e-05	5.53e-05	CcSEcCtD
Risperidone—Nausea—Docetaxel—prostate cancer	1.25e-05	5.52e-05	CcSEcCtD
Risperidone—Dyspepsia—Epirubicin—prostate cancer	1.25e-05	5.52e-05	CcSEcCtD
Risperidone—Diarrhoea—Prednisone—prostate cancer	1.25e-05	5.49e-05	CcSEcCtD
Risperidone—Decreased appetite—Epirubicin—prostate cancer	1.24e-05	5.45e-05	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—prostate cancer	1.23e-05	5.42e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Epirubicin—prostate cancer	1.23e-05	5.42e-05	CcSEcCtD
Risperidone—Fatigue—Epirubicin—prostate cancer	1.23e-05	5.41e-05	CcSEcCtD
Risperidone—Pain—Epirubicin—prostate cancer	1.22e-05	5.36e-05	CcSEcCtD
Risperidone—Constipation—Epirubicin—prostate cancer	1.22e-05	5.36e-05	CcSEcCtD
Risperidone—Nausea—Capecitabine—prostate cancer	1.21e-05	5.35e-05	CcSEcCtD
Risperidone—Dizziness—Prednisone—prostate cancer	1.2e-05	5.3e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.2e-05	5.29e-05	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—prostate cancer	1.19e-05	5.25e-05	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—prostate cancer	1.18e-05	5.21e-05	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—prostate cancer	1.18e-05	5.17e-05	CcSEcCtD
Risperidone—Feeling abnormal—Epirubicin—prostate cancer	1.17e-05	5.17e-05	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—prostate cancer	1.17e-05	5.16e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Epirubicin—prostate cancer	1.17e-05	5.13e-05	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—prostate cancer	1.16e-05	5.11e-05	CcSEcCtD
Risperidone—Vomiting—Prednisone—prostate cancer	1.16e-05	5.1e-05	CcSEcCtD
Risperidone—Rash—Prednisone—prostate cancer	1.15e-05	5.06e-05	CcSEcCtD
Risperidone—Dermatitis—Prednisone—prostate cancer	1.15e-05	5.05e-05	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—prostate cancer	1.15e-05	5.05e-05	CcSEcCtD
Risperidone—Headache—Prednisone—prostate cancer	1.14e-05	5.02e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.14e-05	5.01e-05	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—prostate cancer	1.14e-05	5e-05	CcSEcCtD
Risperidone—Urticaria—Epirubicin—prostate cancer	1.13e-05	4.98e-05	CcSEcCtD
Risperidone—Pain—Doxorubicin—prostate cancer	1.13e-05	4.96e-05	CcSEcCtD
Risperidone—Constipation—Doxorubicin—prostate cancer	1.13e-05	4.96e-05	CcSEcCtD
Risperidone—Body temperature increased—Epirubicin—prostate cancer	1.13e-05	4.96e-05	CcSEcCtD
Risperidone—Abdominal pain—Epirubicin—prostate cancer	1.13e-05	4.96e-05	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—prostate cancer	1.09e-05	4.78e-05	CcSEcCtD
Risperidone—Nausea—Prednisone—prostate cancer	1.08e-05	4.76e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.08e-05	4.75e-05	CcSEcCtD
Risperidone—Hypersensitivity—Epirubicin—prostate cancer	1.05e-05	4.62e-05	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—prostate cancer	1.05e-05	4.61e-05	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—prostate cancer	1.04e-05	4.59e-05	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—prostate cancer	1.04e-05	4.59e-05	CcSEcCtD
Risperidone—Asthenia—Epirubicin—prostate cancer	1.02e-05	4.5e-05	CcSEcCtD
Risperidone—Pruritus—Epirubicin—prostate cancer	1.01e-05	4.44e-05	CcSEcCtD
Risperidone—Diarrhoea—Epirubicin—prostate cancer	9.75e-06	4.29e-05	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—prostate cancer	9.71e-06	4.28e-05	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—prostate cancer	9.46e-06	4.16e-05	CcSEcCtD
Risperidone—Dizziness—Epirubicin—prostate cancer	9.42e-06	4.15e-05	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—prostate cancer	9.33e-06	4.11e-05	CcSEcCtD
Risperidone—Vomiting—Epirubicin—prostate cancer	9.06e-06	3.99e-05	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—prostate cancer	9.02e-06	3.97e-05	CcSEcCtD
Risperidone—Rash—Epirubicin—prostate cancer	8.98e-06	3.95e-05	CcSEcCtD
Risperidone—Dermatitis—Epirubicin—prostate cancer	8.98e-06	3.95e-05	CcSEcCtD
Risperidone—Headache—Epirubicin—prostate cancer	8.93e-06	3.93e-05	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—prostate cancer	8.72e-06	3.84e-05	CcSEcCtD
Risperidone—Nausea—Epirubicin—prostate cancer	8.46e-06	3.73e-05	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—prostate cancer	8.38e-06	3.69e-05	CcSEcCtD
Risperidone—Rash—Doxorubicin—prostate cancer	8.31e-06	3.66e-05	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—prostate cancer	8.3e-06	3.66e-05	CcSEcCtD
Risperidone—Headache—Doxorubicin—prostate cancer	8.26e-06	3.64e-05	CcSEcCtD
Risperidone—Nausea—Doxorubicin—prostate cancer	7.83e-06	3.45e-05	CcSEcCtD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.35e-06	1.3e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—prostate cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SRC—prostate cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—STAT3—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—RXRA—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EP300—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SRC—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—prostate cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—prostate cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CREBBP—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—prostate cancer	1.31e-06	1.26e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.31e-06	1.26e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.31e-06	1.26e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SRC—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—EP300—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—COMT—prostate cancer	1.29e-06	1.24e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—prostate cancer	1.29e-06	1.24e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	1.29e-06	1.24e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.29e-06	1.24e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SRC—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTEN—prostate cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—INS—prostate cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTEN—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTEN—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—prostate cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EP300—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—prostate cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—prostate cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TYMS—prostate cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EP300—prostate cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EP300—prostate cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—EP300—prostate cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—prostate cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—prostate cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NOS3—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SRC—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—prostate cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—prostate cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SRC—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—LPL—prostate cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SRC—prostate cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—prostate cancer	1.15e-06	1.11e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—prostate cancer	1.15e-06	1.11e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.15e-06	1.11e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—prostate cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—prostate cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.14e-06	1.09e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—prostate cancer	1.14e-06	1.09e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.13e-06	1.09e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.13e-06	1.09e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—prostate cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—prostate cancer	1.12e-06	1.07e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NOS3—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—prostate cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CB—prostate cancer	1.09e-06	1.05e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.09e-06	1.05e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—prostate cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—prostate cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—prostate cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—prostate cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—prostate cancer	1.05e-06	1.01e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.04e-06	1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—prostate cancer	1.04e-06	1e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—prostate cancer	1.04e-06	1e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—prostate cancer	1.04e-06	9.99e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.04e-06	9.99e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.04e-06	9.97e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—prostate cancer	1.04e-06	9.95e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—prostate cancer	1.03e-06	9.91e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.03e-06	9.9e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.03e-06	9.88e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—prostate cancer	1.03e-06	9.86e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARA—prostate cancer	1.03e-06	9.85e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.02e-06	9.84e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.02e-06	9.8e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.02e-06	9.8e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.02e-06	9.79e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.02e-06	9.79e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.02e-06	9.79e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.02e-06	9.78e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—prostate cancer	1.02e-06	9.77e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—prostate cancer	9.98e-07	9.59e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—prostate cancer	9.97e-07	9.58e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	9.91e-07	9.52e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—prostate cancer	9.91e-07	9.52e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—prostate cancer	9.86e-07	9.47e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—prostate cancer	9.79e-07	9.4e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	9.75e-07	9.37e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—prostate cancer	9.73e-07	9.35e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—prostate cancer	9.68e-07	9.3e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAV1—prostate cancer	9.64e-07	9.26e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—prostate cancer	9.63e-07	9.25e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—prostate cancer	9.63e-07	9.25e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—prostate cancer	9.61e-07	9.23e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—prostate cancer	9.6e-07	9.22e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—prostate cancer	9.59e-07	9.21e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—prostate cancer	9.48e-07	9.11e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	9.46e-07	9.09e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTEN—prostate cancer	9.44e-07	9.06e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—prostate cancer	9.43e-07	9.06e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—prostate cancer	9.43e-07	9.06e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—prostate cancer	9.39e-07	9.02e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—prostate cancer	9.27e-07	8.91e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—prostate cancer	9.07e-07	8.71e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—prostate cancer	9.02e-07	8.67e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—EP300—prostate cancer	9e-07	8.64e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—prostate cancer	8.99e-07	8.64e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTEN—prostate cancer	8.89e-07	8.54e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	8.85e-07	8.5e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—prostate cancer	8.83e-07	8.48e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—prostate cancer	8.82e-07	8.47e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.78e-07	8.43e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—prostate cancer	8.77e-07	8.43e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—prostate cancer	8.76e-07	8.42e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—prostate cancer	8.7e-07	8.36e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—prostate cancer	8.67e-07	8.33e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	8.66e-07	8.32e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—prostate cancer	8.64e-07	8.3e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—prostate cancer	8.56e-07	8.22e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—prostate cancer	8.54e-07	8.2e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—EP300—prostate cancer	8.48e-07	8.15e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—prostate cancer	8.38e-07	8.05e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—prostate cancer	8.37e-07	8.04e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—prostate cancer	8.32e-07	8e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—INS—prostate cancer	8.31e-07	7.98e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CREBBP—prostate cancer	8.14e-07	7.82e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—prostate cancer	8.1e-07	7.78e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	8.05e-07	7.73e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—prostate cancer	7.97e-07	7.65e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—prostate cancer	7.96e-07	7.65e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—prostate cancer	7.86e-07	7.55e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—prostate cancer	7.83e-07	7.53e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—prostate cancer	7.82e-07	7.51e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—prostate cancer	7.79e-07	7.48e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.72e-07	7.41e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—prostate cancer	7.67e-07	7.37e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—prostate cancer	7.35e-07	7.06e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NOS3—prostate cancer	7.29e-07	7e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—prostate cancer	7.23e-07	6.94e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—prostate cancer	7.21e-07	6.93e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—prostate cancer	7.21e-07	6.92e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—prostate cancer	7.13e-07	6.85e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—prostate cancer	7.08e-07	6.8e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.73e-07	6.46e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—prostate cancer	6.67e-07	6.4e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—prostate cancer	6.66e-07	6.39e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—prostate cancer	6.58e-07	6.32e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.27e-07	6.03e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTEN—prostate cancer	5.81e-07	5.58e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—EP300—prostate cancer	5.54e-07	5.33e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—prostate cancer	5.44e-07	5.22e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—prostate cancer	5.12e-07	4.92e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.1e-07	3.94e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—prostate cancer	3.35e-07	3.22e-06	CbGpPWpGaD
